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Stem Cell Induction Via Inkjet-Mediated Gene Transfection

Abstract
by
Gilbert Paquian Jr.
In 2009 and 2011, it was shown that micropores in the cell membrane that form during
inkjet cell printing are a potential vector for gene transfection1,2. These papers showed that
porcine aortic endothelial cells and Chinese hamster ovary cells were coprinted with green
fluorescent protein-coding (GFP) plasmids onto collagen or gelatin “biopaper” substrates.
Printed cells showed a viability of ~90% with transfection efficiencies ranging from 2-30%1,2.
Using inkjet-mediated gene transfection (IMGT) to insert a plasmid coding for the Yamanaka
stem cell induction factors, it may be possible to offset common drawbacks of the induction
process, such as low efficiency, throughput, and teratoma formation through transgene
reactivation.

Based on initial concerns that substrates may interfere with IMGT due to potential
absorption or destruction of printed DNA, a protocol was developed for printing cells without
using any substrate such as collagen gels or gelatin coating. Human foreskin fibroblasts (HFF),
STO fibroblasts, and Btc-6 Beta cells were printed into varying amounts of culture medium, to
absorb shock, in a 48-well plate, and observed for 7 days after printing. After a recuperation
period, which ranged from 12 to 24 hours, printed cells, even those that were printed into no
culture medium at all, began growing normally, however, printed Beta cells grew slower than
manually seeded controls, not reaching confluency in the wells for up to 10 days post-print.
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HFFs and Beta cells were coprinted with a GFP plasmid to test IMGT on these cells. Of
the two, only the Beta cells showed any fluorescence post-print, with transfection efficiencies up
to 13.2%. Beta cells were then coprinted with, T7-VEE-OKS-iG a plasmid coding for Oct4,
Sox2, Klf4, and Glis-1, which are common factors used to induce pluripotency in somatic cells3.
Bioink containing cells and plasmid DNA in PBS was printed into wells containing growth
medium. At 14 days post-transfection, liposome-transfected controls and printed cells displayed
morphological changes and resistance to selection antibiotics, however they did not form typical
IPS cell colonies, which may indicate that beta cells are not receptive to nonviral transfection
methods for induction.

These results demonstrate that while HFFs, STO fibroblasts and BTC-6 Beta cells can
remain viable post-print without a biopaper substrate, and that IMGT can be used to transfect
Beta cells with a GFP-coding plasmid. IMGT is not currently suitable for transfecting a single
plasmid containing four transcription factors for induction into beta cells. This is likely due to the
large size of the plasmid (16.8 kb), compared to the size of the generated micropores. It may be
possible, however, to generate IPS cell using IMGT as smaller vectors become available. IMGT
should not be ruled out, due to the fact that different cell types may display varying levels of
membrane disruption, thus potentially allowing for larger plasmids to be transfected.
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Chapter 1: Introduction
STEM CELL INDUCTION AND CHALLENGES
Since the discovery that somatic cells could be induced into a pluripotent state that was
similar to embryonic stem cells, in both morphology and function by Dr. Shinya Yamanaka in
2006, stem cell research has surged despite ethical and religious concerns about stem cells and
their uses4,5. This discovery opened the path for the development of personalized stem cell
therapies derived from patient specific cells6,7. Originally, induced pluripotent stem cells (iPSCs)
were generated using retroviral vectors to transfect somatic mouse and human fibroblasts with
four transcription factors commonly found in embryonic and pluripotent cells: Oct3/4, Klf4,
Sox2, and c-Myc4. However, due to the integrative nature of retroviral transfection, coupled with
the tumorigenicity of c-Myc, research has directed to making iPSCs safer for patient studies8,9.
By using non-integrative transfection methods such as Sendai Virus, and Nucleofection of
plasmids, along with different combinations of genetic factors which avoid the use of c-Myc and
other oncogenes, iPSC generation has become safer and more efficient10–12. However, induction
is still a time-consuming, expensive (depending on the methods), and sometimes technically
challenging process6.

INKJET MEDIATED GENE TRANSFECTION
Inkjet cell printing has been explored as a method for digitally accurate and reproducible
cell deposition since 2003 when Wilson and Boland showed that modified inkjet printers could
successfully print Bovine Aortic Endothelial (BAE) cells10. Studies showed that cells could be
printed into different formations and locations using easy-to-use software such as Microsoft
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Powerpoint, and inkjet printing could generate tissue-like constructs such as skin grafts with
embedded endothelial cells, fibroblasts, and keratinocytes11–15. As the usefulness of the process
was shown, questions were raised as to the exact effect of inkjet printing on cellular morphology,
long-term viability and function. Xu et al. and Cui et al. showed that inkjet printing generates
transient pores on the cell membrane that close after approximately two hours, and that printed
cells can successfully be cultured for long periods post print, and that cells can even be printed in
vivo1. An unexpected finding of these experiments what that these generated micropores on the
cell membrane could be used to insert plasmids or nanoparticles into cells with little risk to
overall cell viability1. This process, which will be referred to as Inkjet-Mediated Gene
Transfection (IMGT) has shown transfection efficiencies similar to those of liposome-mediated
gene transfection.

PROJECT RATIONALE
Inkjet Mediated Gene Transfection has the ability to mitigate many of the current issues
with stem cell induction. Seeing as IMGT is a physical method of gene transfection that would
have to use plasmids as the vectors for delivering the induction factors, genomic integration
could easily be avoided6,16. Compared to other physical methods of gene transfection, specifically
electroporation, IMGT shows significantly higher cell viability, which translates into comparable
efficiency overall1,17. Because IMGT does not require any expensive chemical reagents it is also
more cost effective than other transfection methods1,2. Lastly, IMGT presents a novel advantage
over other current methods: high throughput10–13. Compared to other induction methods, which
occur over several hours or even days, IMGT can be done in minutes, which allows for rapid
testing of different plasmid concentrations or other variables. Ultimately induction is a process
that does take days or even weeks to occur completely, but by simplifying the transfection
2

process, more focus can be placed on improving the efficiency of induction through different
genetic or chemical factors4,5,8,18. This project also provides an opportunity for inkjet cell printing
and IMGT to be further evaluated.

HYPOTHESIS AND OBJECTIVE
Printed STO, HFF, and Btc-6 Beta cells can survive without being printed onto substrates such
as collagen or gelatin.

IMGT can be used to deliver a GFP-coding plasmid to HFFs and Beta cells.

IMGT can be used to deliver a VEE-derived plasmid containing Oct4, Klf4, Sox2 and Glis1 into
Human Foreskin Fibroblasts or Btc-6 Beta cells, generating iPSCs.
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Chapter 2: Literature Review
INDUCED PLURIPOTENT STEM CELLS IN TISSUE ENGINEERING
Since the isolation in culture of pluripotent stem cells in 1981, scientists have been
exploring their potential for use in fields ranging from tissue engineering to personalized
medicine6,18–21. Their ability to grow indefinitely and differentiate into any somatic cell type
through a combination of genetic and environmental factors makes them incredibly useful for
studying cell development and growth, however, religious and ethical debates as to their
acquisition and use, have hindered their potential4,19,22. In 2006, Dr. Shinya Yamanaka showed
that pluripotency could be induced into somatic cells by transfecting them with a combination of
specific genetic factors4,5. Induced pluripotent stem (iPS) cells have greatly increased the
potential uses of stem cells into personalized medicine, including patient-specific drug testing,
and tissue engineering, as well as regenerative medicine6.

Figure 2.1. The Promise of Induced Pluripotent Stem Cells in Research and Therapy23
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Generation of Induced Pluripotent Stem Cells
In 2006, Mouse Embryonic Fibroblasts (MEFs) and Tail-Tip Fibroblasts (TTFs) were
transfected with 4 transcription factors coding for pluripotency using retroviral vectors, yielding
cells that were similar in morphology, and function to embryonic stem (ES) cells23. After
transplantation into nude mice these iPS cells were observed to form tumors containing cells
from all 3 germ layers: endoderm, mesoderm and endoderm4. In 2007, Human Dermal
Fibroblasts (HDFs) were reprogrammed to be pluripotent through retroviral transfection of these
same four factors. These cells were differentiated into various cell types by culturing them into
embryoid bodies then transferring them onto gelatin-coated well plates5. When implanted into
nude mice, iPS cells generates from HDFs also developed teratomas containing cells fro all 3
germ layers was well indicating successful induction5,8.

Pluripotency Conferring Factors and the Oncogene c-Myc
Experiments that have shown that unfertilized eggs and fusion with ES cells can confer
pluripotency to somatic cells through specific factors4,22. 24 of these factors were identified and
tested in various combinations, by retrovirally transfecting them into mouse and then human
fibroblasts42. The four factors that were found to most effectively induce pluripotency were
Oct3/4, Klf4, Sox2, and c-Myc (OKSM Factors). Oct3/4, and Sox2 are both important for
maintaining pluripotency in early embryos and ES cells. Klf4 and c-Myc, typically upregulated
in tumors, help contribute to rapid proliferation of ES cells and maintenance of the ES cell
phenotype4. Across several experiments, these four genes, sometimes in combination with others,
have been shown to efficiently generate iPS cells using various transfection methods5,24–27.
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Figure 2.2. Pluripotency of iPS cells generated from MEFs using viral vectors. A. Various
tissues present in teratomas derived from iPS cells. B. Neural and Muscle tissues
found in teratomas. C. Embryoid body formation (upper row) and differentiation
(lower row)4. Scale bars = 200 μm.

Retroviral transfection of the OKSM factors was thought necessary at first to ensure
adequate and sustained expression of the transgenes during induction due to genomic integration,
however the risk existed that the transgenes could reactivate4,5. In subsequent studies, Okita et al.
found that teratoma formation was linked only to the reactivation of the c-Myc gene and not to
Oct3/4, Sox2, or Klf48. Tumorigenicity resulting from reactivation of c-Myc or other transgenes
due to genomic integration, was one of the main reasons researchers began looking at alternate
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transcription factors and non-integrative transfection methods. Similarly, continued expression of
the transgenes can inhibit differentiation, which in turn could lead to teratoma formation9,26.

iPS cells could be generated by substituting c-Myc with similar transcription factors or
even without Myc entirely using only 3 factors, albeit at a slower pace and lower efficiency, by
delaying drug selection9,27–29. Some replacements for c-Myc include L-Myc, Nanog, LIN28 or
GLIS13,6,20,29–31. GLIS1 in particular was found to generate iPSCs at slightly lower efficiencies
than c-Myc in combination with Oct4, Klf4, and Sox2. OKS + GLIS1 also generated more
uniform colonies with defined borders indicative of successful induction than OKSM treated
cells3. The risks associated with transgene reactivation, including c-Myc, can be avoided through
silencing of the transgenes, but if silencing is performed to soon after transfection, induction may
not occur, leading to investigation into whether induction could occur by using non-integrative
means28.

Non-Integrative Methods of Gene Transfection for iPSC Generation
While c-Myc plays a major role in iPSC generation-related tumorigenicity, another key
factor influencing teratoma formation by iPSCs is the continued expression of transgenes due to
genomic integration4,5,8. Retroviral vectors were used in initial iPSC generation experiments due
to their ability to ensure complete reprogramming through continued expression of the OKSM
factors. This would lead to cells that would remain undifferentiated after being transplanted into
patients, which could potentially form teratomas. Thus, in order to minimize the risk of teratoma
formation, researchers began investigation non-integrative methods of transfecting the induction
factors.

7

In 2009, Fusaki et al. described a method using Sendai virus (SeV) to infect cells with a
single-stranded RNA coding for OKSM factors that does not integrate into the host genome27s.
Previously, SeV vectors were considered for gene therapy for cystic fibrosis, critical limb
ischemia, or vaccines for AIDS6,27. SeV vectors were successfully able to induce pluripotency in
BJ neonatal foreskin fibroblasts and Human dermal fibroblasts HDF) at an efficiency of 1%,
similar to retroviral vectors. IPSCs that expressed transgenes for longer than desired could be
selected and removed by using anti-HN-protein antibodies as HN proteins are expressed in cells
infected with SeV27. Further developments lead to SeV vectors that could induce pluripotency at
efficiencies 100 times greater than standard retroviral vectors with minimal risk for integration or
transgene reactivation30. One important thing to note however while SeV is not pathogenic to
humans, it can still infect human cells, and should transgenes coding for Klf4 or c-Myc be
present, extreme care should be taken while handling viruses30. Also, multiple selection steps are
needed in order to isolate completely virus-free clones27,30.

Alongside the development of SeV-based vectors, plasmids coding for the OKSM factors
were also being developed. In 2008, Okita et al. showed that by transfecting cells with two
plasmids, one coding for Oct4, Klf4, and Sox2, and the other coding for c-Myc, transfected into
cells twice each, over the course of four days could generate iPSCs, albeit at a much lower
efficiency than by retroviral induction (1-29 colonies per 1x106 cells using plasmids vs. 1000
colonies per 1x106 cells using retroviruses)32. Nucleofection was able to transfect Mouse
Embryonic Fibroblasts (MEFs) after just one or two transfections. By inserting plasmids
containing OKSM factors directly into the nucleus, Nucleofection was able to quickly generate
iPSC colonies that expressed ES cell markers and morphology after 3 weeks. However, many of
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the generated clones showed some form of random integration and because of the traumatic
nature of Nucleofection (and electroporation by extension), multiple transfections are not
practical, as the process usually results in significant cell death30,33,34.

To avoid the risk of genomic integration while also attempting to generate iPSCs with a
single transfection, Yoshioka et al. developed a novel method of RNA-based induction that
avoids drawbacks associated with mRNA-based methods, namely the need for multiple
transfections over the course of the induction period. They modified a non-infectious selfreplicating Venezuelan Equine Encephalovirus RNA, which is currently being tested for vaccine
use, to contain all four reprogramming factors and a resistance gene3,35. After initial testing
showed a strong, but expected, innate immune response to the VEE RNA, which interfered with
gene expression, they utilized B18R protein to bind to IFN-α/β ensuing continued expression
over more than a month3,36. After performing multiple transfections of OKSM or OKSG
(utilizing GLIS1 instead of c-Myc), and B18R-coding plasmids using Lipofectamine 2000 over
several days, >100 iPS cell colonies were identified. They further refined the process to only
require a single transfection of OKSM/OKSG + B18R plasmids using Lipofectamine 2000
followed by culture in B18R conditioned medium. This method generated iPS cell colonies in
approximately two weeks and Alkaline Phosphatase staining three-weeks post transfection
verified pluripotency3.

INKJET CELL PRINTING
Since 2003, inkjet bioprinting using modified desktop inkjet printers has been used to
accurately deposit cells on surfaces suitable for cell patterning10. Printed Bovine Aortic
9

Endothelial (BAE) cells retained a high viability and were able to be cultured post-print12. Since
then inkjet printing has been explored as method for creating digitally reproducible cell
microarrays, accurate deposition of cells into substrates for cultures in 3D environments, cell
sorting, and recently as a physical method of cell membrane disruption11,13,13,37–40.

Inkjet printing is a process where ink inside the cartridge gathers inside the nozzles and is
held in place by surface tension. A heating element generates a pressure wave by heating to
temperatures around 300 °C over the course of 1-4 μs which breaks the surface tension and
creates the ink droplet41,42. Originally it was theorized that this process would be too traumatic for
cells to remain viable, similar to laser printing where most cells are lysed during the process,
however it has been shown that both bacterial and mammalian cells can survive the printing
process and remain viable afterwards10,12,38. Any membrane disruption that occurs is usually
repaired within hours of printing, and cells begin growing within a day2.

Inkjet cell printing does have several limitations however. The process is limited to lowviscosity fluids and low cell densities to prevent nozzle clogging40. Also, control of dispensed
drops is lost after they exit the nozzle, which depending on the application could limit is
usefulness42,43. Moreover as printing technology advances, smaller nozzle sizes and more
difficult-to-modify printers limit the selection of useable printers to older models, which are
more difficult to find parts and replacement cartridges for.
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Applications of Inkjet Cell Printing
Initially inkjet cell printing was operated using text-based software, which limited the
application of it to depositing geometrically simple microarrays10,44. However, modifications for
the printer soon allowed for more common software to such as Microsoft Word®, Microsoft
PowerPoint®, or Adobe Photoshop® to create the printable patterns38. Escherichia coli was
printed onto soy agar substrates in the shape of the unofficial Clemson University Logo for
example as shown in Figure 2. 238. Chinese Hamster Ovary (CHO) cells and rat primary
embryonic motorneurons were printed to test mammalian cell viability. CHO cells successfully
proliferated for >20 days post-print, and motorneurons successfully differentiated over the course
of 7 days12,39. Over 90% of printed cells remained viable, showing that not only could cells
survive the printing process, but they could also continue to grow and function properly postprint.
Xu et al conducted one of the first experiments utilizing cell inkjet printing to generate a
functional tissue construct. NT2-derived neurons were printed in layers along with fibrin and
thrombin onto a microscope coverslip. The NT2 cells were suspended in this fibrinogen
hydrogel, and cultured in NT2 medium. Using patch-clamp tests, the presence of voltage-gated
ion channels on the membranes of printed cell was verified, and action potential firing was
recorded. The neuronal cells in the 3D construct successfully attached to the fibrin gel and
remained viable post-print while also exhibiting little to no sign of heat shock effects from the
printing process39.
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Figure 2.3. Photograph of Eschrichia coli printed into the shpe of a paw using the inkjet
method38.
Thermal inkjet printing was also used to develop microvasculature in fibrinogen
hydrogels, to potentially overcome one of the major obstacles in tissue engineering, being the
formation of vasculature to nourish cells within tissue constructs14,45. Similar to the last
experiment, Human Microvascular endothelial cells (HMVECs) were coprinted with fibrin and
thrombin to generate a fibrinogen hydrogel with embedded cells which were printed in a tubular
shape. Printed cells were able to proliferate and connect forming a tubular structure. The
integrity of the printed construct was verified using dextran molecules after 21 days of
incubation (as shown in Figure 2.3)14. This experiment showed that inkjet cell printing could
create microscale structures effectively.
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Figure 2.4. Printed microvasculature and staining with Texas Red conjugated dextran molecules.
A. Printed HMVECs after 14 days of incubation. B. Texas Red staining of day-14
printed HMVECs, showing some defects in the integrity of the structure. C. Printed
HMVECs after 21 days of incubation. D. Texas Red staining of day-21 printed
HMVECs showing significant improvement of integrity though exclusion of nearly
all dextran molecules14.
In another experiment detailing the use of inkjet printing to create 3D constructs, Yanez
et al. showed that by printing HMVECs into collagen gels with embedded HDFs and human
epidermal keratinocytes (HEKn) to create an artificial skin graft for treating full-thickness
wounds. After being implanted into nude mice, the graft allowed for improved healing while also
displaying similar histology. The “neoskin” displayed a similar appearance to normal skin while
also displaying both dermal and epidermal layers with thicknesses similar to normal skin. When
compared to Apligraf controls, the printed skin grafts (keeping in mind that only HMVECs were
printed), the printed skin grafts healed around 10 days faster than the Apligraf treated wounds,
showing improved wound contraction as well15.
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Effects of Inkjet Printing on Printed Cells and Inkjet-Mediated Gene Transfection
As previously stated, during the inkjet printing process, heating element inside each
nozzle of the cartridge heats to approximately 300 °C over the course of 1-4 μs, ejecting the ink
droplets2,41,42. Even with such a dramatic raise in temperature, the ejected droplets, which range in
volume from 10-150 pL, are only heated 4-10 °C above ambient temperatures. Printed droplets
experience a velocity-induced shear stress of about 10 ms-141,42,44. Armed with this knowledge,
researchers sought to understand the overall effect inkjet printing had on the cell body, as it is
well known that cells can react negatively to thermal and mechanical stress. They were also
aware, however, that these effects, if any, were probably transient due to the fact that printed
cells remain viable and functional2.

In 2009, Xu et al. tested for any inkjet-generated membrane permeability while also
elucidating another potential use for inkjet cell printing. They hypothesized that potential
transient membrane permeability could be used to transfect cells with plasmid DNA, similar to
the heat-shock transformation process used on bacteria1,46,47. To ensure that plasmid DNA
remained viable during the print process, plasmid DNA was suspended in Nucleofector solution
and printed. Printed plasmids were electrophoresed in a 1% agarose gel, and then visualized by
UV transillumination to verify that plasmid integrity was maintained during the printing
process1. Porcine Aortic Endothelial (PAE) cells were co-printed along with pmaxGFP and
pIRES-VEGF-GFP plasmids which both code for Green Fluorescent Protein (GFP) onto
collagen gels. This potential transfection method was compared to Lipofectamine 2000 and
Nucleofection (electroporation). Similar to previous experiments, over 90% of printed cell
survived the printing process, compared to 65% of liposome-transfected cells, and 45% of
14

Nulceofected cells. Nucleofected cells had the highest efficiency of transfection (32.3%), while
thermal inkjet printed cells had slightly higher transfection efficiency than liposome transfected
cells (12.8% to 10.6%)1. This experiment confirmed that there must be some membrane
disruption during the inkjet printing process that created microcpores along the cell membrane
allowing the plasmids to pass into the cell. The group also tested whether different printing
conditions and plasmid sizes. PAE cells were coprinted with plasmid DNA from HP 51626a and
HP 51629a cartridges. Cells printed from the HP 51629a cartridges showed higher efficiencies
possibly due to the higher shear stresses generated by the smaller nozzle sizes (14.1% to 4.3%).
The size of the plasmid also affects the transfection efficiency. pmaxGFP which has a size of 3.2
kb was transfected at an efficiency of 14.1%, as opposed to the pIRES-VEGF-GFP plasmid
which had a size of 6.3 kb, and had a transfection efficiency of 1.1%1.

Figure 2.5. Schematic of the Inkjet Mediated Gene Transfection Process. Cells exposed to high
heat, and velocity-induced shear stress while being ejected from the cartridge
develop transient micropores on their membrane allowing for the delivery of genes
and other molecules

15

Figure 2.6. In vitro gene printing results. A. Electrophoresis analysis of printed DNA. Track 1.
Size marker. Track 2. Printed pmaxGFP. Track 3. Non-printed pmaxGFP. Track 4.
Printed pIRES-VGF-GFP. Track 5. Non-printed pIRES-VGF-GFP. B. Printed PAE
cells showing normal morphology. C. Printed PAE cells showing green
fluorescence indicating that transfection was successful. D. Non-printed PAE cells.
E. No detectable fluorescence from non-printed cells indicating that thermal inkjet
printing was the modality by which transfection was achieved. F. Cell viability,
post-transfection. G. Overall transfection efficiency1.

One of the most important advantages of electroporation as a method of transfection is its
high efficiency17,33,34,48. In the previously described experiment, without taking into account cell
viability post-transfection, the efficiency was ~70%1. This is due to the high-energy conditions
that cells are subjected to. Electroporation has been widely studied in terms of gene delivery as a
means of reversibly disrupting the cell membrane. An electrical field is applied to cells, and upon
reaching critical voltage (kV/cm) for ~100 ms, the membrane becomes transiently permeable,
allowing for large plasmids to enter the cytoplasm, and in the case of Nucleofection, the nucleus
of the cell17,34. However many cells undergo permanent damage due to the high voltage and
eventually necrosis occurs resulting in characteristically low cell viability33,48,49. Similarly,
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piezoelectric printing can result in permanent cell damage as it’s operating frequencies, ranging
from 0.5-40 kHz are within the range of frequencies used during sonication to lyse cells (15-25
kHz)11,40.

Based on this reasoning, inkjet printing may prove to be a viable method for

successfully transfecting cells, while retaining high viability and efficiency.

In order to test whether or not the membrane permeabilization of cells during inkjet
printing was transient or not, Cui et al. coprinted CHO cells with Texas Red-conjugated Dextran
molecules and Propidium Iodide (PI)2. The dextran molecules were of various molecular weights
from 3,000 MW to 70,000 MW, in order to identify the size of generated micropores2. PI cannot
normally penetrate cells if they’re healthy and is commonly used to stain fixed cells, but can
enter live cells if the membrane is damaged2. Over the course of two hours post-print, the dextran
molecules and PI were added to printed cells. No significant fluorescence was detected in cells
incubated with 70,000 MW Dextrans, showing that formed micropores were smaller than that.
40,000 and 10,000 MW Dextrans were able to enter cells up to fifteen minutes post-print. 3,000
MW Dextrans were able to enter cells up to an hour after printing. These results are shown in
Figure 2.5. and Table 2.1. PI molecules were able to enter cells up to two hours post-print. These
results showed that the developed micropores close over two hours after printing, leaving cells
totally normal after a brief period post-print2. Seeing as long-term viability of printed cells has
been previously shown, these results indicate that after printing, printed cells can return
completely to normal. Similar to the Xu transfection experiment, Cui et al. attempted to use
inkjet printing to transfect cells with a GFP plasmid. CHO cells were coprinted with fibrillarinGFP, which was successfully able to enter printed cells through generated micropores. Cells
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were transfected at an efficiency of up to ~32%, again indicating the potential usefulness of
inkjet printing as a physical method for gene transfection2.

Figure 2.7. Cell membrane penetration of Texas Red-conjugated Dextran molecules 1 hour
after printing. The first column shows the original GFP expression from CHO cells.
The second column shows the Texas Red fluorescence from cells which the
Dextran molecules were able to enter. The third column shows the combination of
the two channels. The fourth column shows the DIC image of the cells. A. Dextran
3,000; B. Dextran 10,000; C. Dextran 40,000; D. Dextran 70,0002.

Table 2.1.

Cell membrane penetration post-print. A ✓ indicated that the molecule entered the
cell and an O indicated that the molecule did not enter the cell2.
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Chapter 3: Materials and Methods
CELL CULTURE
Three types of cells were used in this experiment: STO mouse fibroblasts, Human
Foreskin Fibroblasts (HFFs), and Btc-6 Beta Cells (Beta Cells). STO cells were a generous gift
from Dr. Joddar (Biomedical Engineering Professor at the University of Texas at El Paso). Cells
were cultured in T-25 culture flasks, passaged at 70-80% confluency, and incubated at 5% CO2
and at 37 C. Flasks used for STO culture were coated with 1% gelatin solution as per
recommendation from Dr. Joddar. HFFs and STOs were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS). Beta cells were
cultured in DMEM supplemented with 15% FBS. Media for all cell types was changed every 2
days.

CELL SUSPENSION (BIO-INK) PREPARATION
Confluent cells were washed with Phosphate Buffer Solution (PBS), trypsinized (1 mL of
trypsin per T-25 flask). Trypsinized cells were centrifuged at 1500 rpm for 5 minutes to remove
trypsin then washed with PBS again to remove any traces of trypsin. Cells were resuspended in
culture medium then counted using a hemocytometer. Cell concentration was adjusted postcount. Bio-ink was prepared by centrifuging cells at 1500 rpm for 5 minutes then resuspending
cells in 1x PBS. Final concentrations for printed cells ranged from 1x106 cells/mL to 8x106
cells/mL.
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PRINTER AND CARTRIDGE PREPARATION
A modified HP Desktop 550 printer and HP 51626a cartridge were used for this
experiment. The printer was modified as described previously10. A new cartridge is prepared for
printing by opening it on the top and draining ink out of the cartridge, if any, then washing it out
with diH2O. Sonication can be used to break up residual ink that may have dried inside the
nozzles should the cartridge be past its expiration date. The cartridge is then rinsed with 70%
ethanol to sterilize it before printing. It is recommended to print several times with PBS or
diH2O to wash out any residual ethanol, prior to printing with bioinks. Between prints, if
clogging occurs, sonication may be used to break up any residue in the nozzles.

Figure 3.1. Modified HP 550 Printer used in this experiment. Aluminum stage can be adjusted up
or down to allow printing onto various surfaces.
SUBSTRATELESS PRINTING PROTOCOL DEVELOPMENT
Bioink was prepared as described, using HFFs and STOs, with a final cell concentration
of ~4x106 cells/mL. Printing patterns for 48-well plates were created using Adobe Photoshop®.
Layer control in Photoshop allowed for selection of specific wells to print in. Due to size
constraints of the printer stage only 6 rows (36 wells) could be printed into at any one time.
20

Various amounts of culture medium were added to wells, ranging from 0 μL to 500 μL, in
increments of 125 μL (3 wells per volume), to serve as a cushion for ejected cells. 40 μL of bioink was added to the cartridge and 10 copies were printed into all wells. Cartridge was refilled
with 40 μL of PBS and 5 more copies were printed to ensure that any residual cells were
deposited. 250 μL of culture medium was added to the wells that did not contain medium that
cells were printed into. As a control, cells were manually seeded rather than printed into wells at
similar concentrations. Cells were observed using an inverted microscope immediately after
printing, and every day after for 6 days. Cells were trypsinized and counted on day 3 and day 7.

PLASMID DNA PURIFICATION
3 plasmids were used during this experiment. pEGFP-n1 plasmid was a gift from Dr.
Varela (Biology Research Assistant, University of Texas at El Paso). T7-VEE-OKS-iG
(Addgene plasmid # 58974), and pTNT-B18R (Addgene plasmid # 58978) were gifts from Dr.
Steven Dowdy. Each plasmid was contained in Escherichia coli bacteria, and was purified using
the same methods. Using a headed collection hook, colonies of bacteria were left to culture
overnight in 150 mL of LB broth supplemented with selection anti-biotic (Kanamycin for
pEGFP-n1, and Ampicillin for T7-VEE-OKS-iG, and pTNT-B18R). Plasmids were purified
using the Promega PureyieldTM Plasmid Purification Kit (Promega Corporation, Madison, WI),
and accompanying protocol. Briefly, bacteria was centrifuged to remove LB, and resuspended
using supplied resuspension solution. Bacteria was lysed, and then centrifuged again to separate
bacterial debris. Lysate was filtered using a vacuum manifold and supplied Pureyield Clearing
Columns. Remaining solution was washed and re-filtered using the Pureyield Binding Column.
Plasmids were eluted using a swinging-bucket rotor centrifuge and nuclease-free water. Plasmid
concentration was verified using Nanodrop 2000 spectrophotometer, and plasmid integrity was
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shown through agarose gel electrophoresis. Prior to use, plasmid concentration was adjusted to
250 ng/μL by adding nuclease-free water (ethanol precipitation was not needed).

VERIFICATION OF IMGT VIA PRINTED TRANSFECTION OF PEGFP-N1
Bioink was prepared as described above, using HFFs and Beta cells. STOs were omitted
due to concerns that future experiments attempting to reprogram STOs while culturing them on
STO feeder cells would interfere with the induction process. 40 μL of bioink at a cell
concentration of 4x106 cells/mL was added to the cartridge along with eGFP-n1 (0.25 μg-‐2	
  μg).	
  
Using	
  patterns	
  created	
  in	
  Adobe	
  Photoshop®,	
  cells	
  and	
  plasmid	
  were	
  printed	
  into	
  3	
  wells	
  of	
  
a	
   48-‐well	
   plate,	
   with	
   each	
   well	
   containing	
   150	
   μL	
   of	
   culture	
   medium.	
   Cartridge	
   was	
  
sonicated	
   and	
   cleaned	
   with	
   70%	
   ethanol	
   after	
   each	
   print.	
   Negative	
   controls	
   were	
   cells	
   that	
  
were	
   manually	
   seeded	
   into	
   well	
   plates	
   along	
   with	
   pEGFP-‐n1,	
   and	
   cells	
   that	
   were	
   printed	
  
into	
  wells	
  without	
  plasmid.	
  Culture	
  Medium	
  was	
  changed	
  24	
  hours	
  post-‐print,	
  then	
  ever	
  48	
  
hours	
  after	
  that.	
  Printed	
  cells	
  were	
  observed	
  for	
  fluorescence	
  24	
  hours,	
  then	
  72	
  hours	
  post-‐
print	
  using	
  a	
  Ziess	
  Axiovert	
  2000	
  inverted	
  fluorescent	
  microscope.	
  Transfection	
  efficiency	
  
was	
  calculated	
  by	
  dividing	
  the	
  number	
  of	
  fluorescent	
  cells	
  by	
  the	
  total	
  number	
  of	
  cells	
  in	
  a	
  
40x	
  magnification	
  field.	
  One	
  field	
  was	
  selected	
  from	
  each	
  of	
  the	
  3	
  wells.

LIPOSOME TRANSFECTION OF PEGFP-N1
As a positive control for the IMGT of pEGFP-n1, pEGFP-n1 was transfected into HFFs
and Beta cells. Lipofectamine® LTX and PlusTM Reagent, a gift from Dr. Varela (Biology
Research Assistant, University of Texas at El Paso), was used following the manufacturer’s
protocol. Briefly, HFFs and Beta cells were seeded into wells of a 48 well plate, and allowed to
grow till they were 70-80% confluent. Upon reaching confluency, culture medium was removed
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and 150 μL	
   of	
   fresh	
   medium	
   was	
   added.	
   Lipofectamine	
   LTX	
   Reagent	
   was	
   diluted	
   using	
  
DMEM,	
   without	
   serum.	
   pEGFP-‐n1	
   plasmid	
   (0.25 μg-‐2	
   μg)	
   was	
   added	
   to	
   Plus	
   Reagent,	
   and	
  
also	
  diluted	
  using	
  DMEM.	
  Diluted	
  Lipofectamine	
  LTX	
  and	
  diluted	
  Plus/plasmid	
  were	
  mixed	
  
together	
   and	
   allowed	
   to	
   incubate	
   for	
   5	
   minutes	
   at	
   room	
   temperature.	
   Plasmid-‐
Lipofectamine	
   complex	
   was	
   then	
   added	
   to	
   wells	
   containing	
   Betas	
   and	
   HFFs.	
   Culture	
  
Medium	
  was	
  changed	
  24	
  hours	
  post-‐print,	
  then	
  ever	
  48	
  hours	
  after	
  that.	
  Transfected	
  cells	
  
were	
  observed	
  for	
  fluorescence	
  24	
  hours,	
  then	
  72	
  hours	
  post-‐print	
  using	
  a	
  Ziess	
  Axiovert	
  
2000	
   inverted	
   fluorescent	
   microscope.	
   Transfection	
   efficiency	
   was	
   calculated	
   by	
   dividing	
  
the	
  number	
  of	
  fluorescent	
  cells	
  by	
  the	
  total	
  number	
  of	
  cells	
  in	
  a	
  40x	
  magnification	
  field.	
  One	
  
field	
  was	
  selected	
  from	
  each	
  of	
  the	
  3	
  wells.	
  

PREPARATION OF B18R-CM
In order to prevent innate immune response from cells transfected with VEE-derived
plasmid RNA, without multiple transfections of a B18R coding-plasmid, pTNT-B18R will be
transfected into HFFs to condition media with B18R protein (B18R-CM). Using Lipofectamine
LTX and Plus Reagent, HFFs were treated with pTNT-B18R plasmid (1 μg	
  per	
  1	
  well	
  of	
  a	
  6-‐
well	
   plate)	
   according to manufacturer protocols. Transfected cells were then cultured in
Advanced DMEM (ADMEM) supplemented with 15% FCS or Essential 8TM stem cell medium.
Every day, media was collected, filtrated, and diluted with fresh culture medium to a
concentration of 20%.

REPROGRAMMING OF HFF AND BETA CELLS USING T7-VEE-OKS-IG
Yoshioka et al. developed a protocol by which a single transfection of T7-VEE- OKS-iG
+ pTNT-B18R could be used to induce pluripotency in cells. This protocol was chosen due to the
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fact that it was able to generate stem cells with a single transfection of a plasmid vector, which
addresses the difficulty of performing multiple transfections using IMGT on the same group of
cells repeatedly. That protocol is replicated in this experiment, albeit the printer was used as the
method of transfection in the experimental group, and Lipofectamine LTX and Plus Reagent was
used in the control group. Bioink was prepared using HFFs and Beta cells, with a cellular
concentration of 5x106 cells/mL to account for the increased number of wells to be printed in. 1.5
μg	
  of	
  T7-‐VEE-‐OKS-‐iG	
  and	
  1.5	
  μg	
  of	
  pTNT-‐B18R	
  were	
  mixed	
  into	
  bioink	
  to	
  deliver	
  0.25	
  μg	
  of	
  
each	
   plasmid	
   to	
   each	
   well,	
   consistent	
   with	
   Lipofectamine	
   LTX	
   protocols.	
   Bioink/plasmid	
  
complex	
  was	
  printed	
  into	
  6	
  wells	
  of	
  a	
  48	
  well	
  plate,	
  each	
  containing	
  ADMEM	
  +	
  15%	
  FCS	
  +	
  
20%	
  B18R-‐CM.	
  The	
  transfection	
  of	
  B18R-‐coding	
  plasmid	
  along	
  with	
  the	
  induction	
  plasmid	
  
served	
   to	
   help	
   ensure	
   proper	
   initial	
   expression	
   of	
   the	
   induction	
   genes.	
   Media	
   was	
   replaced	
  
every	
  day.	
  Puromycin	
  (0.8	
  μg/μL)	
  was	
  added	
  from	
  day	
  2	
  to	
  10,	
  in	
  3	
  of	
  the	
  6	
  wells.	
  On	
  day	
  7,	
  
medium	
  was	
  switched	
  to	
  Essential	
  8	
  medium	
  supplemented	
  with	
  20%	
  B18R-‐CM.	
  On	
  day	
  10	
  
cells	
   were	
   passaged	
   onto	
   STO	
   feeder	
   cells	
   inactivated	
   with	
   Mitomycin-‐C.	
   For	
   positive	
  
controls,	
   Lipofectamine-‐LTX	
   and	
   Plus	
   Reagent	
   was	
   used	
   as	
   the	
   transfection	
   methods,	
  
following	
   manufacturer	
   protocols.	
   Negative	
  controls	
  utilized	
  manually	
  seeded	
  cells	
  mixed	
  
with	
  plasmids.	
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Chapter 4: Results
SUBSTRATELESS PRINTING PROTOCOL DEVELOPMENT
HFFs, STOs and Beta cells were deposited into wells via inkjet printing using a pattern
developed in Adobe Photoshop. Patterns for well plates of different sizes were also developed,
however a 48 well plate was used for experimentation. Printed cells were able to attach and
grow, even when printing into wells with no media in them, indicating that despite the lack of
cushion for printing, cells could survive the process and remain functional. HFF cells would
attach to the well ~4 hours post-print, and begin growing, shown in Figure 4.1. STO cells, as
expected would not attach to wells if gelatin coating was not present, however, after >5 passages
of subculture, STOs would attach to T-flasks that were not gelatin-coated. These STOs could be
printed onto, and would attach to well plates that were not gelatin-coated and grow at similar
rates to manually seeded controls. Beta cells were the least receptive to printing without a
substrate. Printed cells would settle to the bottom of the well and remain circular for several
hours post-print, usually not showing signs of attachment till at least >12 hours post-print. Cells
in the center of the well would remain circular, with little to no signs of growth while cells closer
to the edges of the well plate would begin to grow and form typical Beta cell colonies. Printed
STOs and HFFs would typically reach confluency 4-5 days post-print while Beta cells would
usually take longer, up to 7-10 days, due to the lower number of viable cells. It may be possible
that the printing process, combined with the lack of substrate to print on may have been too
traumatic for printed Beta cells. Results are shown in Figures 4.1 and 4.2.
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A	
  

C	
  

B	
  

D	
  

Figure 4.1. Printed HFFs and Beta Cells. A. HFFs 1 Day post-print and B. HFFs 3 Days PostPrint. C. Betas 1 Day Post-Print. D. Betas 3 Days Post Print. Scale Bars = 100 μm.
VERIFICATION OF IMGT VIA PRINTED TRANSFECTION OF PEGFP-N1
HFFs and Beta cells were coprinted with pEGFP-n1 plasmid, at amounts varying from
0.25	
  μg	
  –	
  2	
  μg.	
  HFFs	
  coprinted	
  with	
  plasmid	
  showed	
  no	
  fluorescence	
  1	
  or	
  3	
  days	
  post-‐print,	
  
even	
  with	
  2	
  μg	
  of	
  DNA.	
  This	
  reflects	
  results	
  from	
  Lipofectamine	
  transfection	
  of	
  HFFs,	
  which	
  
were	
   transfected	
   with	
   efficiencies	
   of	
   <1%.	
   Detected	
   fluorescence	
   was	
   also	
   very	
   faint.	
  
Several	
  experiments	
  varying	
  conditions	
  such	
  as	
  using	
  non-‐serumated	
  medium	
  to	
  perform	
  
the	
   transfections	
   (which	
   is	
   recommended	
   in	
   some	
   protocols),	
   and	
   varying	
   the	
   amount	
   of	
  
liposome	
  used	
  failed	
  to	
  yield	
  higher	
  efficiencies.	
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Figure 4.2. Graphs showing comparison of cell grown between printed STOs, HFFs, and Beta
cells. These show the growth of cells printed into 250 μL
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Beta	
  cells	
  however,	
  showed	
  some	
  transfection	
  when	
  coprinted	
  along	
  with	
  plasmid.	
  
Cells	
   showed	
   <1%	
   efficiencies	
   when	
   transfected	
   with	
   <1	
   μg	
   plasmid.	
   Cells	
   transfected	
   with	
  
>1μg	
   of	
   plasmid	
   showed	
   efficiency	
   comparable	
   to	
   Lipofectamine	
   transfected	
   cells	
   (8.6-‐
13.2%	
   compared	
   to	
   9.3-‐15.7%),	
   however,	
   printed	
   Betas	
   suffered	
   from	
   drawbacks	
  
described	
  previously,	
  namely	
  low	
  cell	
  viability	
  and	
  attachment	
  post-‐print.	
  	
  

Figure 4.3. Beta Cells transfected with pEGFP-n1 via IMGT on Day 3 post-print. Scale Bars =
500 μm
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Figure 4.4. Comparison of transfection efficiency between IMGT and Lipofectamine LTX and
Plus reagent. Higher plasmid concentrations did affect efficiency.
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ATTEMPTED INDUCTION OF HFFS AND BETA CELLS
	
  
HFFs	
   and	
   Beta	
   cells	
   were	
   transfected	
   with	
   0.25	
   of	
   VEE-‐T7-‐OKS-‐iG	
   and	
   0.25	
   μg	
   of	
  
pTNT-‐B18R	
  using	
  either	
  IMGT	
  or	
  Lipofectamine	
  LTX	
  and	
  Plus	
  reagent.	
  Experimental	
  cells	
  
were	
   printed/seeded	
   into	
   6	
   wells	
   for	
   2	
   sets	
   of	
   3	
   wells.	
   Control	
   cells	
   were	
   seeded	
   into	
   wells	
  
manually	
   and	
   plasmid	
   was	
   pipetted	
   into	
   the	
   wells.	
   T7-‐VEE-‐OKS-‐iG	
   contains	
   a	
   resistance	
  
gene	
  for	
  Puromycin.	
  No	
  Puromycin	
  resistant	
  cells/colonies	
  were	
  noted	
  in	
  printed	
  HFFs	
  by	
  
day	
  4,	
  and	
  by	
  day	
  7	
  no	
  cellular	
  growth	
  was	
  noted,	
  indicating	
  failed	
  transfection.	
  Similarly,	
  
in	
   printed	
   Beta	
   cells,	
   no	
   Puromycin	
   resistant	
   colonies	
   were	
   noted,	
   albeit	
   later,	
   on	
   day	
   6.	
   All	
  
Puromycin-‐treated	
  Beta	
  cells	
  had	
  detached	
  by	
  day	
  10	
  (Figure	
  4.	
  5).	
  	
  
	
  
In	
   non-‐Puromycin	
   treated	
   printed	
   and	
   Lipofectamine-‐transfected	
   HFFs,	
   no	
  
morphology	
   changes	
   were	
   observed	
   in	
   any	
   cells	
   up	
   to	
   day	
   15	
   when	
   experiment	
   was	
  
concluded.	
   HFFs	
   have	
   very	
   distinct,	
   elongated	
   morphologies,	
   whereas	
   typical	
   iPSC	
   colonies	
  
show	
   round	
   morphologies	
   and	
   tend	
   to	
   group	
   together	
   into	
   colonies.	
   HFFs	
   were	
   treated	
  
with	
  Essential	
  8	
  medium	
  supplemented	
  with	
  20%+B18R-‐CM	
  from	
  day	
  7	
  on,	
  as	
  directed	
  by	
  
the	
  protocol	
  given	
  by	
  Yoshioka	
  et	
  al3.	
  	
  
	
  
In	
   non-‐Puromycin	
   treated	
   printed	
   Beta	
   cells,	
   no	
   morphological	
   changes	
   were	
  
observed	
   either,	
   till	
   Day	
   24	
   when	
   experiment	
   was	
   ended.	
   The	
   reasoning	
   for	
   extending	
  
experimental	
   duration	
   will	
   be	
   described	
   in	
   the	
   next	
   section.	
   While	
   Beta	
   cells	
   typically	
   form	
  
small	
   irregular	
   clusters	
   in	
   normal	
   culture,	
   in	
   another	
   experiment	
   Beta	
   cells	
   being	
  
reprogrammed	
  began	
  forming	
  regular,	
  larger	
  colonies	
  indicating	
  induction,	
  around	
  18	
  days	
  
after	
  transfection50.	
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In	
   one	
   well	
   of	
   non-‐treated	
   Lipofectamine-‐transfected	
   Beta	
   cells,	
   on	
   day	
   6	
   several	
  
cells,	
  which	
  appeared	
  to	
  have	
  elongated	
  morphologies,	
  emerged,	
  and	
  a	
  colony	
  of	
  cells	
  not	
  
resembling	
   a	
   typical	
   beta	
   cell	
   colony	
   was	
   observed	
   (Figure	
   4.6).	
   Cells	
   were	
   cultured	
   in	
  
Essential	
   8	
   medium	
   supplemented	
   with	
   20%	
   B18R-‐CM	
   from	
   day	
   7	
   onward.	
   Contamination	
  
was	
   ruled	
   out	
   due	
   to	
   the	
   fact	
   that	
   Beta	
   cells	
   and	
   Fibroblasts	
   were	
   kept	
   in	
   separate	
   well-‐
plate.	
  While	
  the	
  same	
  print	
  cartridge	
  had	
  been	
  used	
  to	
  print	
  both	
  HFFs	
  and	
  Fibroblasts,	
  the	
  
cartridge	
   had	
   been	
   subjected	
   to	
   several	
   sonications	
   and	
   ethanol	
   sterilizations	
   when	
  
switching	
  
B	
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Figure 4.5. HFFs and Beta cells after being treated with Puromycin at 7 days post-transfection.
A. Non-puromycin treated HFFs. B. Puromycin-treated HFFs. C. Non-puromycin
treated Beta cells. D. Puromycin Treated Beta cells. Scale Bars = 500 μm
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between	
   cell	
   types.	
   This	
   colony	
   and	
   elongated	
   cells	
   were	
   observed	
   to	
   grow	
   over	
   the	
   next	
  
two	
  weeks.	
  However,	
  no	
  other	
  colony	
  formation	
  was	
  noted	
  during	
  the	
  observation	
  period.	
  
In	
   order	
   to	
   assess	
   whether	
   or	
   not	
   these	
   cells	
   were	
   successfully	
   transfected,	
   Puromycin	
   was	
  
added	
   to	
   the	
   well	
   on	
   Day	
   18.	
   By	
   day	
   22,	
   most	
   of	
   the	
   unusual	
   cells	
   had	
   detached	
   or	
   died,	
  
along	
  with	
  the	
  untransfected	
  beta	
  cells,	
  and	
  the	
  colony	
  had	
  shrunken.	
  By	
  day	
  24	
  no	
  more	
  
unusual	
   cells	
   could	
   be	
   observed.	
   This	
   indicates	
   that	
   cells	
   may	
   have	
   been	
   transfected,	
   but	
  
not	
   successfully	
   reprogrammed.	
   As	
   Yoshioka	
   et	
   al.	
   observed	
   successful	
   induction	
  
efficiencies	
  of	
  around	
  0.025%,	
  this	
  is	
  to	
  be	
  expected3.	
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Figure 4.6. Irregular cells growing with non-Puromycin treated, Lipofectamine-transfected Beta
cells. A. 20x magnification showing spreading of dendritic cells along the cell
surface with Beta cells on the outside of the frame. B. 40x magnification focusing
on the unique colony that does not resemble typical Beta cell colonies. C. Cellular
detachment observed on Day 22.
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Chapter 5: Discussion
DISCUSSION
Inkjet cell printing is a fairly novel technology with many potential applications11,13. In
this study it was shown, contrary to previous publications that cells could survive the inkjet
printing process even without the need for a “biopaper” substrate to help cushion ejected cells.
Printed HFFs and STOs grew at rates similar to manually seeded cells after a brief resting period
and achieved confluency at the same time. Beta cells were more affected by the printing process
but also grew and achieved confluency eventually. Substrateless printing of viable cells may be
useful for not only for transfections, but also for example seeding of stem cells onto inactivated
fibroblast feeder layers. Substrateless printing of cells was also used as a method of cell
separation and sorting, by printing cells labeled with magnetic particles51.

It was also shown in this study that Beta cells could successfully be transfected using
IMGT with a plasmid coding for GFP expression at efficiencies up to 13.2%. This is the first
report of Beta cells being transfected using this method. This provides an easy, high-throughput,
and low-cost method for transfecting Beta cells. It is important to consider that the moderate
efficiency of induction (when compared to previous reports) may be attributed to the size of
pEGFP-n1 plasmid, 4.7 kb, which is on the larger end of transfectable plasmids as currently
reported. Many of the author’s colleagues in the lab work with Beta cells and the potential for
them to be able to transfect Beta cells with a GFP plasmid for quick identification of living cells
could prove to be useful.
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Stem cell induction remains a lucrative field of study with multiple areas of
improvement6,21,52. The problem of the oncogene c-Myc and its usage has been eliminated
through the use of alternate transfection methods or through other genetic factors, however nonintegrative methods for transfection of the induction genes remain expensive or timeconsuming9,27,53. Using IMGT may still yet resolve these issues yet iPSC colonies could not be
generated using a single transfection of T7-VEE-OKS-iG plasmid and the Yoshioka protocol. It
is the author’s belief that the main reason for this failure was due to the large size of the T7VEE-OKS-iG plasmid (16.8 kb). Plasmids successfully transfected using IMGT range from 3.26.3 kb, however, it has been shown that some cell types are more affected by the inkjet printing
process than others, meaning that the potential to insert larger plasmids into cells yet exists2,54.
Also, as research into induction methods and transcription factors progresses, smaller
combinations of factors in different arrangements mean that smaller and smaller molecules could
be used for transfection, making IMGT appealing. Carpio et al. reported generating iPSCs from
Human Primary Fibroblasts by multiple transfections a combination of 3 factors Oct4, Klf4, and
Sox 2 in different arrangements (linear and circular DNA, and mRNA)55. While IMGT is not
suitable for multiple transfections of induction genes due to the need to trypsinize and resuspend
cells each time, the author believes it is only a matter of time before sufficiently small plasmids,
nanoparticles or mRNAs that only require a single transfection to induce pluripotency are
generated bringing IMGT into the picture again55–57. IMGT does still retain the advantage of
high-throughput and low cost when compared to other transfection methods, and still remains an
alternative for other applications where physical methods of transfections are preferred and
smaller plasmids are used.
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IMPACT OF THE WORK
Inkjet printing of viable cells could be conducted without the use of a substrate to
facilitate cell attachment or cushion cells from trauma due to the printing process and ejection
from the cartridge. IMGT was also shown to be able to transfect Btc-6 Beta cells with a 4.7 kb
plasmid.

FUTURE WORK
A natural extension of this work would be to attempt to transfect different cell types with
plasmids using IMGT, as it has been further shown that different cell types are differently
susceptible to membrane permeabilization due to inkjet printing. By identifying cells that have a
more positive response to IMGT, we can further attempt to transfect larger and larger particles
using this method.

Another aspect to consider when performing experiments using inkjet cell printing or
IMGT is the lack of standardization between printing protocols. Cell concentration while
printing, and the composition of bioinks vary depending on application, however within IMGT
applications cell concentration varies widely in the published reports. It is possible that a higher
cell concentration could result in more cells being in the nozzles during printing which would
lead to higher shear stress thus potentially increasing the generation of micropores and their size.
While studying the potential of IMGT, a set of standards on bioink composition and cell
concentration should be established between publications to more accurately reflect efficiencies
of transfected cells.
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When considering IMGT use for iPSC generation, it is important to keep abreast of novel
techniques for induction. As many methods of induction now require insertion of smaller
numbers of transcription factors in smaller packages, it is possible that the problem of generated
micropores being too small to accept induction vectors, may soon disappear. It may also be
possible to alter existing protocols in such a way as to generate iPSCs with only a single
transfection of induction factors, which would be advantageous if IMGT were to be used.
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